![Luisa Salter-Cid](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Luisa Salter-Cid
Corporate Officer/Principal bei
Flagship Pioneering, Inc.
Profil
Dr. Luisa Salter-Cid is a Chief Scientific Officer, Pioneering Medicines at Flagship Pioneering, Inc. Dr. Salter-Cid was previously employed as a Chief Scientific Officer by Gossamer Bio, Inc. and a Vice President & Head-Immunology by Bristol Myers Squibb Co. She also served on the board at Jounce Therapeutics, Inc. She received her undergraduate degree from the University of Lisbon, a graduate degree from Florida International University and a doctorate degree from The University of Miami Leonard M.
Miller School of Medicine.
Aktive Positionen von Luisa Salter-Cid
| Unternehmen | Position | Beginn |
|---|---|---|
Flagship Pioneering, Inc.
 Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Corporate Officer/Principal | 01.05.2021 |
Ehemalige bekannte Positionen von Luisa Salter-Cid
| Unternehmen | Position | Ende |
|---|---|---|
| JOUNCE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 03.05.2023 |
| GOSSAMER BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 30.04.2021 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.08.2018 |
Ausbildung von Luisa Salter-Cid
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
64
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
Florida International University
 Florida International University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Lisbon
 University of Lisbon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immunotherapy company that develops therapies to treat cancer | Health Technology |
The University of Miami Leonard M. Miller School of Medicine
 The University of Miami Leonard M. Miller School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gossamer Bio, Inc.
 Gossamer Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing therapeutics for immunology, inflammation and oncology diseases | Health Technology |
